Regenxbio
RGNX
RGNX
170 hedge funds and large institutions have $717M invested in Regenxbio in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 61 reducing their positions, and 20 closing their positions.
Holders
170
Holders Change
+12
Holders Change %
+7.59%
% of All Funds
2.49%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
32
Increased
47
Reduced
61
Closed
20
Calls
$1.74M
Puts
$2.02M
Net Calls
-$279K
Net Calls Change
-$2.69M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$65.4M |
| 2 |
RG
2
Redmile Group
San Francisco,
California
|
$67.5M |
| 3 |
PA
3
Perceptive Advisors
New York
|
$6.15M |
| 4 |
IHAM
4
Integral Health Asset Management
New York
|
$5.83M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$70.7M |
Top Sellers
| 1 |
1
Balyasny Asset Management
Chicago,
Illinois
|
$3.52M |
| 2 |
2
First Manhattan
New York
|
$190K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$3.81M |
| 4 |
ECM
4
ExodusPoint Capital Management
New York
|
$0 |
| 5 |
5
Goldman Sachs
New York
|
$6.03M |
